Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 9;31(3):1445-1459.
doi: 10.3390/curroncol31030109.

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

Miklos Acs  1 , Pompiliu Piso  2 , Gabriel Glockzin  3
Affiliations
Review

Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations

Miklos Acs et al. Curr Oncol. .

Abstract

Peritoneal metastasis is a common finding in patients with advanced gastric cancer. Beyond systemic chemotherapy, additive local treatments such as cytoreductive surgery and intraperitoneal chemotherapy are considered an inherent part of different multimodal treatment concepts for selected patients with peritoneal metastatic gastric cancer. This review article discusses the role of cytoreductive surgery (CRS) and intraperitoneal chemotherapy, including HIPEC, NIPS, and PIPAC, as additive therapeutic options with curative and palliative intent.

Keywords: HIPEC; NIPS; PIPAC; cytoreductive surgery; gastric cancer; intraperitoneal chemotherapy; peritoneal metastasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Proposed treatment algorithm for patients with peritoneal metastatic gastric cancer (pmGC).
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Ikeguchi M., Oka A., Tsujitani S., Maeta M., Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res. 1994;14:2131–2134. - PubMed
    1. Riihimaki M., Hemminki A., Sundquist K., Sundquist J., Hemminki K. Metastatic spread in patients with gastric cancer. Oncotarget. 2016;7:52307–52316. doi: 10.18632/oncotarget.10740. - DOI - PMC - PubMed
    1. D’Angelica M., Gonen M., Brennan M.F., Turnbull A.D., Bains M., Karpeh M.S. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann. Surg. 2004;240:808–816. doi: 10.1097/01.sla.0000143245.28656.15. - DOI - PMC - PubMed
    1. Sasako M., Sano T., Yamamoto S., Kurokawa Y., Nashimoto A., Kurita A., Hiratsuka M., Tsujinaka T., Kinoshita T., Arai K., et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N. Engl. J. Med. 2008;359:453–462. doi: 10.1056/NEJMoa0707035. - DOI - PubMed

MeSH terms